AI drug discovery company
MindRank
Data as of .
Company facts
-
Founded
2020
-
Headquarters
China (Hangzhou)
Latest funding round
- Round
- Series B
- Date
- Jul 10, 2026
- Amount
- $52M
Drug discovery partners
1 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
3SBio Pharma
China commercialization partnership for oral GLP-1,
Drugs on the board
- MDR-001 (GLP-1 agonist)
Phase 3 registry
Overweight or obesity
Recent news
-
Partners with 3SBio to commercialize its AI-designed oral GLP-1 in China
-
Announces a $52M Series B
-
Peptide design paper with Qingdao University accepted at ICML 2026
-
First patient dosed in Phase 3 MOBILE trial of MDR-001
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.